| EQ-5D-5L | SF-6Dv2 | ||||||
---|---|---|---|---|---|---|---|---|
 | Mean (SD) | p value | Scheffe post hoc test | Effect size a (95% CI) | Mean (SD) | p value | Scheffe post hoc test | Effect size a (95% CI) |
BMI group |  | < 0.001 |  | 0.517 (0.327, 0.706) |  | < 0.001 |  | 0.383 (0.194, 0.571) |
 I: 24 ≤ BMI < 26 (N = 406) | 0.882 (0.165) |  | I > III***, I > IV***, II > III***, II > IV*** |  | 0.756 (0.153) |  | I > III**, I > IV**, II > III**, II > IV** |  |
 II: 26 ≤ BMI < 28 (N = 271) | 0.876 (0.160) |  |  | 0.749 (0.137) |  |  | ||
 III: 28 ≤ BMI < 30 (N = 151) | 0.784 (0.248) |  |  | 0.693 (0.191) |  |  | ||
 IV: BMI ≥ 30 (N = 172) | 0.794 (0.230) |  |  | 0.694 (0.187) |  |  | ||
Health status |  | < 0.001 |  | 1.717 (1.407, 2.023) |  | < 0.001 |  | 2.329 (1.989, 2.625) |
 I: Excellent (n = 79) | 0.986 (0.036) |  | I > III***, I > IV***, II > III***, II > IV***, III > IV*** |  | 0.915 (0.101) |  | I > II***, I > III***, I > IV***, II > III***, II > IV***, III > IV*** |  |
 II: Good (n = 314) | 0.944 (0.086) |  |  | 0.830 (0.103) |  |  | ||
 III: Fair (n = 440) | 0.846 (0.166) |  |  | 0.707 (0.108) |  |  | ||
 IV: Bad (n = 167) | 0.622 (0.256) |  |  | 0.540 (0.183) |  |  | ||
Number of chronic diseases |  | < 0.001 |  | 1.885 (1.664, 2.105) |  | < 0.001 |  | 2.076 (1.850, 2.303) |
 I: 0 (N = 410) | 0.940 (0.112) |  | I > II**, I > III***, I > IV***, I > V***, II > III**, II > IV***, II > V***, III > V***, IV > V*** |  | 0.835 (0.116) |  | I > II***, I > III***, I > IV***, I > V***, II > III**, II > IV***, II > V***, III > V***, IV > V*** |  |
 II: 1 (N = 182) | 0.892 (0.137) |  |  | 0.743 (0.119) |  |  | ||
 III: 2 (N = 169) | 0.819 (0.147) |  |  | 0.683 (0.118) |  |  | ||
 IV: 3 (N = 96) | 0.773 (0.202) |  |  | 0.656 (0.114) |  |  | ||
 V: ≥4 (N = 143) | 0.630 (0.262) |  |  | 0.548 (0.189) |  |  |